Editor's note: This article was originally published in 2016 and has been updated for 2018. We practitioners of the technological arts have a tendency to use specialized jargon. That's not unusual.

Bristol Myers Squibb (NYSE:BMY) was a stock I mentioned in my weekly stock webinar last week on the topic of stopping volume and I want to follow up on that here as it has developed into an excellent ...

Walmart (NYSE:WMT) is another US stock that exhibited classic signs of weakness around the same time as Pfizer (NYSE:PFE), but what is interesting here is the recent injection of volume which appeared ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

This content has been created by the Finextra editorial team with inputs from subject matter experts at the funding sponsor. 15 years ago, innovation had stalled. Banks were licking their compliance ...

Government departments and CPSEs have continued to fail dismally in meeting targets for procuring from SC/ST and women-owned MSEs. Organisations that deliver the highest quality of service or products ...